Literature DB >> 29348192

Differential Contributions of Nucleus Accumbens Subregions to Cue-Guided Risk/Reward Decision Making and Implementation of Conditional Rules.

Stan B Floresco1, David R Montes2, Maric M T Tse2, Mieke van Holstein2.   

Abstract

The nucleus accumbens (NAc) is a key node within corticolimbic circuitry for guiding action selection and cost/benefit decision making in situations involving reward uncertainty. Preclinical studies have typically assessed risk/reward decision making using assays where decisions are guided by internally generated representations of choice-outcome contingencies. Yet, real-life decisions are often influenced by external stimuli that inform about likelihoods of obtaining rewards. How different subregions of the NAc mediate decision making in such situations is unclear. Here, we used a novel assay colloquially termed the "Blackjack" task that models these types of situations. Male Long-Evans rats were trained to choose between one lever that always delivered a one-pellet reward and another that delivered four pellets with different probabilities [either 50% (good-odds) or 12.5% (poor-odds)], which were signaled by one of two auditory cues. Under control conditions, rats selected the large/risky option more often on good-odds versus poor-odds trials. Inactivation of the NAc core caused indiscriminate choice patterns. In contrast, NAc shell inactivation increased risky choice, more prominently on poor-odds trials. Additional experiments revealed that both subregions contribute to auditory conditional discrimination. NAc core or shell inactivation reduced Pavlovian approach elicited by an auditory CS+, yet shell inactivation also increased responding during presentation of a CS-. These data highlight distinct contributions for NAc subregions in decision making and reward seeking guided by discriminative stimuli. The core is crucial for implementation of conditional rules, whereas the shell refines reward seeking by mitigating the allure of larger, unlikely rewards and reducing expression of inappropriate or non-rewarded actions.SIGNIFICANCE STATEMENT Using external cues to guide decision making is crucial for adaptive behavior. Deficits in cue-guided behavior have been associated with neuropsychiatric disorders, such as attention deficit hyperactivity disorder and schizophrenia, which in turn has been linked to aberrant processing in the nucleus accumbens. However, many preclinical studies have often assessed risk/reward decision making in the absence of explicit cues. The current study fills that gap by using a novel task that allows for the assessment of cue-guided risk/reward decision making in rodents. Our findings identified distinct yet complementary roles for the medial versus lateral portions of this nucleus that provide a broader understanding of the differential contributions it makes to decision making and reward seeking guided by discriminative stimuli.
Copyright © 2018 the authors 0270-6474/18/381901-14$15.00/0.

Entities:  

Keywords:  Pavlovian; accumbens; action selection; conditional discrimination; decision making; reward

Mesh:

Year:  2018        PMID: 29348192      PMCID: PMC6705881          DOI: 10.1523/JNEUROSCI.3191-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  22 in total

1.  Relative contributions and mapping of ventral tegmental area dopamine and GABA neurons by projection target in the rat.

Authors:  Jocelyn M Breton; Annabelle R Charbit; Benjamin J Snyder; Peter T K Fong; Elayne V Dias; Patricia Himmels; Hagar Lock; Elyssa B Margolis
Journal:  J Comp Neurol       Date:  2018-12-11       Impact factor: 3.215

2.  Disinhibition of the Nucleus Accumbens Leads to Macro-Scale Hyperactivity Consisting of Micro-Scale Behavioral Segments Encoded by Striatal Activity.

Authors:  Dorin Yael; Orel Tahary; Boris Gurovich; Katya Belelovsky; Izhar Bar-Gad
Journal:  J Neurosci       Date:  2019-05-24       Impact factor: 6.167

3.  Effect of chronic alcohol vapor exposure on reinstatement of alcohol seeking induced by U50,488.

Authors:  Douglas Funk; Kathleen Coen; Sahar Tamadon; A D Lê
Journal:  Neuropharmacology       Date:  2019-01-16       Impact factor: 5.250

4.  Cortico-Striatal Control over Adaptive Goal-Directed Responding Elicited by Cues Signaling Sucrose Reward or Punishment.

Authors:  Laurie Hamel; Bilgehan Cavdaroglu; Dylan Yeates; David Nguyen; Sadia Riaz; Dylan Patterson; Nisma Khan; Nardin Kirolos; Katherine Roper; Quynh An Ha; Rutsuko Ito
Journal:  J Neurosci       Date:  2022-03-29       Impact factor: 6.709

5.  Distinct Medial Orbitofrontal-Striatal Circuits Support Dissociable Component Processes of Risk/Reward Decision-Making.

Authors:  Nicole L Jenni; Griffin Rutledge; Stan B Floresco
Journal:  J Neurosci       Date:  2022-02-08       Impact factor: 6.709

6.  Medial orbitofrontal cortex and nucleus accumbens mediation in risk assessment behaviors in adolescents and adults.

Authors:  Maxine K Loh; Nicole C Ferrara; Jocelyn M Torres; J Amiel Rosenkranz
Journal:  Neuropsychopharmacology       Date:  2022-01-17       Impact factor: 8.294

7.  Dissociable roles for the ventral and dorsal medial prefrontal cortex in cue-guided risk/reward decision making.

Authors:  Mieke van Holstein; Stan B Floresco
Journal:  Neuropsychopharmacology       Date:  2019-10-25       Impact factor: 7.853

Review 8.  The Periaqueductal Gray and Its Extended Participation in Drug Addiction Phenomena.

Authors:  Priscila Vázquez-León; Abraham Miranda-Páez; Jesús Chávez-Reyes; Gonzalo Allende; Paulino Barragán-Iglesias; Bruno A Marichal-Cancino
Journal:  Neurosci Bull       Date:  2021-07-24       Impact factor: 5.271

Review 9.  Advances in understanding meso-cortico-limbic-striatal systems mediating risky reward seeking.

Authors:  Patrick T Piantadosi; Lindsay R Halladay; Anna K Radke; Andrew Holmes
Journal:  J Neurochem       Date:  2021-04-19       Impact factor: 5.546

10.  Challenges and Opportunities in Animal Models of Gambling-like Behavior.

Authors:  Cole Vonder Haar
Journal:  Curr Opin Behav Sci       Date:  2019-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.